SeQuent Scientific Limited (SeQuent) announced that its wholly owned subsidiary SeQuent Research Limited (SRL) has received Establishment Inspection Report (EIR) from US FDA for its state- of-the art GLP compliant, Analytical services laboratory at Bengaluru.
The Bengaluru laboratory was set up in 2017 to cater to the growing analytical requirements of large pharmaceutical and FMCG majors in the region. The facility is equipped with best-in-class infrastructure, strong team of trained analytical scientists and LIMS-enabled Quality Management System.
SRL also has another US FDA approved analytical laboratory at Mangaluru, which has been providing services since 2008. The Mangaluru laboratory was successfully inspected by the US FDA in December 2018.
Shares of SEQUENT SCIENTIFIC LTD. was last trading in BSE at Rs.71.5 as compared to the previous close of Rs. 69.65. The total number of shares traded during the day was 40711 in over 649 trades.
The stock hit an intraday high of Rs. 72.15 and intraday low of 69.05. The net turnover during the day was Rs. 2888045.